Showing results (31-40 of 432) with videos related to
Sort By:
Pageof 44
Schizophrenia Bulletin|July 10, 2007
Molecular targets for treating cognitive dysfunction in schizophreniaJohn A Gray, Bryan L RothTrends in Pharmacological Sciences|March 12, 2003
Salvinorin A: the "magic mint" hallucinogen finds a molecular target in the kappa opioid receptorDouglas J Sheffler, Bryan L RothThe Journal of Clinical Investigation|December 3, 2013
Lorcaserin and pimavanserin: emerging selectivity of serotonin receptor subtype-targeted drugsHerbert Y Meltzer, Bryan L RothBrain Research|October 16, 2012
Pharmacosynthetics: Reimagining the pharmacogenetic approachMartilias S Farrell, Bryan L RothBiochemical Pharmacology|June 30, 2024
Molecular glues as potential GPCR therapeuticsBryan L Roth, Brian E KrummMolecular Cell|July 21, 2023
Built-in functional selectivity in neurons is mediated by the neuronal protein, GINIPNicholas J Kapolka, Bryan L RothAnnual Review of Neuroscience|July 9, 2014
Chemogenetic tools to interrogate brain functionsScott M Sternson, Bryan L RothCell Chemical Biology|November 17, 2023
CryoEM structures of adhesion in GPCR CD97: Filling in some of the gapsBrian E Krumm, Bryan L RothStructure (London, England : 1993)|August 5, 2022
Structural insights from G-protein-coupled receptor complexes enable the rational engineering of improved light-activated designer receptorsNicholas J Kapolka, Bryan L RothPageof 44